gsk-598809

GSK598809 is a selective D(3)R antagonist recently progressed in Phase I trials. GSK-598809 may decrease the rewarding effects of contextual cues associated with drug intake preclinically, which may reduce drug craving in humans.

(-)-GSK598809 is an isomer of GSK598809 that is a potent and selective antagonist of dopamine D3 Receptor.

GSK-598809 L-tartrate sesquihydrate is an acute D3 antagonist.

GSK-598809 L-tartrate is an acute D3 antagonist.

Aspafilioside B is a steroidal saponin extracted from Asparagus filicinus that inhibits the growth and proliferation of HCC cell lines.

(-)-GSK598809 hydrochloride 是 GSK598809 的异构体。GSK598809 是多巴胺 D3 受体 (DRD3) 的选择性拮抗剂，是一种选择性增强货币政策期间的神经反应药物和酒精依赖中的奖励预期，可能修复物质依赖中的奖励缺陷。

Eucatropine，作为一种有效的毒蕈碱型乙酰胆碱受体(mAChR)抑制剂，具有0.583 μM的IC50值，归类为抗胆碱能剂。

TZP-102 is a potent, oral, ghrelin receptor agonist that has been shown to improve diabetic gastroparesis symptoms.